News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
HK Stocks Experience 'Fundraising Activity Wave'; ZA ONLINE Once Dips 10%, CHINAHONGQIAO Continues to Break Ceiling; Innovative Drug Stocks Subtract as REMEGEN Dives 25%
Amid a 'fundraising activity wave' by companies, Hong Kong stocks retreated this morning (26th) after gaining for four consecutive days. The HSI opened 129 points lower at ...
Reset
Send
The window will close in 5 seconds
HK Stocks Experience 'Fundraising Activity Wave'; ZA ONLINE Once Dips 10%, CHINAHONGQIAO Continues to Break Ceiling; Innovative Drug Stocks Subtract as REMEGEN Dives 25%
Close
Recommend
48
Positive
74
Negative
59
 
 

Amid a 'fundraising activity wave' by companies, Hong Kong stocks retreated this morning (26th) after gaining for four consecutive days. The HSI opened 129 points lower at 24,345 before dropping 233 points to a low of 24,240 in the early session. The index then narrowed its losses. It last slid 90 points or nearly 0.4% to 24,383, with a turnover of $125.318 billion. The HSTECH ascended after opening lower, and ticked up 0.25% to last at 5,371.

ZA ONLINE (06060.HK)  0.000 (0.000%)    Short selling $746.56M; Ratio 22.707%   once tumbled 10.3% to a low of $17.88 before narrowing its losses. It last printed at $19.32, down 3.11%, with a turnover of $2.169 billion as the company announced an 8.5% discounted share placement, raising a net amount of nearly $3.9 billion.

Related NewsUBS Raises TPs for CSPC PHARMA/ CARSGEN-B to HKD10/ HKD32
CHINAHONGQIAO (01378.HK)  0.000 (0.000%)    Short selling $159.90M; Ratio 17.475%   issued a positive profit alert earlier expecting an about 35% YoY increase in 1H25 net profit. The stock opened 0.2% lower this morning before hiking, and peaked at a new historical high of $17.78. It last printed at $17.6, climbing 2.56%, with a turnover of $368 million.

Innovative drug concept A-shares were under pressure, dragging down H-shares. REMEGEN (09995.HK)  0.000 (0.000%)    Short selling $150.32M; Ratio 5.662%   granted Vor Bio exclusive development rights for Telitacicept outside Greater China. However, REMEGEN's A-shares last sank over 14% to close at RMB57.35 near noon. REMEGEN's H-shares opened 14.77% lower this morning, and once collapsed over 25% to a low of $50.05 in the early session. It last printed at $56.65, down 15.51%, with a turnover of $1.924 billion.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-26 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.